ID

14653

Descripción

Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00841113

Link

https://clinicaltrials.gov/show/NCT00841113

Palabras clave

  1. 25/4/16 25/4/16 -
Subido en

25 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00841113

Eligibility Prostate Cancer NCT00841113

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven prostate cancer and not previously treated with hormones
Descripción

Prostate Cancer and its treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2,1]
C0332155
UMLS CUI [2,2]
C0279025
evidance of advanced disease or metastases
Descripción

Advanced disease or metastases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0679246
UMLS CUI [2]
C0027627
life expectancy of at least 3 months
Descripción

Life expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
normal serum testosterone levels
Descripción

Serum testosterone measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428413
written informed consent
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous endocrine or cytoxic theapy for prostate cancer
Descripción

Hormone therapy and chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279025
UMLS CUI [2]
C0392920
known tumour complication of prostate cancer which owuld require immediate treatment
Descripción

Cancer complication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0596237
another malignancy other than basal cell cancer
Descripción

Further malignancy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0007114
history of significant drug hypersensitivity to either lhrh agonists or gnrh antagonists.
Descripción

Allergies

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1518041
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1268855
congenital or acquired coagulation disorders contraindicating intramuscular injections
Descripción

Coagulation disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005779
pagets disease of the bone
Descripción

Pagets disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029401
qtcb > 450 msec at day - 14
Descripción

QTcB

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1882512

Similar models

Eligibility Prostate Cancer NCT00841113

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Prostate Cancer and its treatment
Item
histologically proven prostate cancer and not previously treated with hormones
boolean
C0600139 (UMLS CUI [1])
C0332155 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
Advanced disease or metastases
Item
evidance of advanced disease or metastases
boolean
C0679246 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
Life expectancy
Item
life expectancy of at least 3 months
boolean
C0023671 (UMLS CUI [1])
Serum testosterone measurement
Item
normal serum testosterone levels
boolean
C0428413 (UMLS CUI [1])
Informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hormone therapy and chemotherapy
Item
previous endocrine or cytoxic theapy for prostate cancer
boolean
C0279025 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
Cancer complication
Item
known tumour complication of prostate cancer which owuld require immediate treatment
boolean
C0596237 (UMLS CUI [1])
Further malignancy
Item
another malignancy other than basal cell cancer
boolean
C0006826 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
Allergies
Item
history of significant drug hypersensitivity to either lhrh agonists or gnrh antagonists.
boolean
C0020517 (UMLS CUI [1,1])
C1518041 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1268855 (UMLS CUI [2,2])
Coagulation disorder
Item
congenital or acquired coagulation disorders contraindicating intramuscular injections
boolean
C0005779 (UMLS CUI [1])
Pagets disease
Item
pagets disease of the bone
boolean
C0029401 (UMLS CUI [1])
QTcB
Item
qtcb > 450 msec at day - 14
boolean
C1882512 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial